Abstract:Regulatory T cells (Tregs) constitute a small proportion of circulating CD4 + T cells that function to maintain homeostasis and prevent autoimmunity. In light of their powerful immunosuppressive and tolerance-promoting properties, Tregs have become an interesting potential candidate for therapeutic use in conditions such as solid organ transplant or to treat autoimmune and inflammatory conditions. Clinical studies have demonstrated the safety of polyclonally expanded Tregs in graft-versus-host disease, type 1 diabetes, and more recently in renal and liver transplantation. However, Tregs are heterogenous. Recent insights indicate that only a small proportion of Tregs, called T follicular regulatory cells (Tfr) regulate interactions between B cells and T follicular helper (Tfh) cells within the germinal center. Tfr have been mainly described in mouse models due to the challenges of sampling secondary lymphoid organs in humans. However, emerging human studies, characterize Tfr as being CD4 + CD25 + FOXP3 + CXCR5 + cells with different levels of PD-1 and ICOS expression depending on their localization, in the blood or the germinal center. The exact role they play in transplantation remains to be elucidated. However, given the potential ability of these cells to modulate antibody responses to allo-antigens, there is great interest in exploring translational applications in situations where B cell responses need to be regulated. Here, we review the current knowledge of Tfr and the role they play focusing on human diseases and transplantation. We also discuss the potential future applications of Tfr therapy in transplantation and examine the evidence for a role of Tfr in antibody production, acute and chronic rejection and tertiary lymphoid organs. Furthermore, the potential impact of immunosuppression on Tfr will be explored. Based on preclinical research, we will analyse the rationale of Tfr therapy in solid organ transplantation and summarize the different challenges to be overcome before Tfr therapy can be implemented into clinical practice.

Follicular Regulatory T Cells: a Novel Target for Immunotherapy?

Follicular Regulatory T Cell Biology and Its Role in Immune-Mediated Diseases

T Follicular Helper Cells, T Follicular Regulatory Cells And Autoimmunity

T Follicular Helper Cells, T Follicular Regulatory Cells and Autoimmunity.

Targeting TFH Cells in Human Diseases and Vaccination: Rationale and Practice

Frontiers of Autoantibodies in Autoimmune Disorders: Crosstalk Between Tfh/Tfr and Regulatory B Cells

Targeting T FH cells in human diseases and vaccination: rationale and practice

Potential Application of T-Follicular Regulatory Cell Therapy in Transplantation

T Follicular Regulatory Cells: Choreographers of Productive Germinal Center Responses

New Insights into Follicular Regulatory T Cells in the Intestinal and Tumor Microenvironments

Follicular Regulatory T Cells Repress Cytokine Production by Follicular Helper T Cells and Optimize IgG Responses in Mice

T Follicular Helper Cells in Autoimmune Diseases.

Deficiency in T Follicular Regulatory Cells Promotes Autoimmunity

Regulation of Follicular T Helper Cell Differentiation in Antitumor Immunity

Follicular T-helper cells: controlled localization and cellular interactions.

Transcriptional and epigenetic regulation of follicular T-helper cells and their role in autoimmunity

B Cell-T Cell Interplay in Immune Regulation: A Focus on Follicular Regulatory T and Regulatory B Cell Functions

Effects of Allergen Immunotherapy on Follicular Regulatory T Cells

Advances in T follicular helper and T follicular regulatory cells in transplantation immunity

Insights into the Molecular Mechanisms of T Follicular Helper-Mediated Immunity and Pathology

Biology and Clinical Relevance of Follicular Cytotoxic T Cells.